Lovotibeglogene Autotemcel

CAS nullBiologic

Overview

Lovotibeglogene Autotemcel is a gene therapy product developed for the treatment of hemoglobin disorders such as sickle cell disease. It involves the ex vivo modification of a patient's hematopoietic stem cells to produce functional hemoglobin.

Therapeutic areas

Hematology
Verified Supplier Partner

Do you supply Lovotibeglogene Autotemcel? Get in front of buyers actively sourcing it.

We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.

No cost to enquire · we only reach out with a fit.

Related APIs

Rivaroxaban
59 suppliers
Apixaban
52 suppliers
Clopidogrel
39 suppliers
Deferasirox
24 suppliers
Azacitidine
18 suppliers
Lenalidomide
17 suppliers
Ibrutinib
16 suppliers
Clopidogrel Bisulfate
13 suppliers

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.

Start free trialBook a demo